Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 1.67 M1.85 M1.72 M1.72 M 6.96 M Research & development ———— — Operating income -46.04 K-1.01 M-719.13 K267.3 K -1.51 M Non-Operating Income, Total 292.53 K451.93 K174.37 K213.51 K 1.13 M Interest expense, net of interest capitalized 599553506458 2 116 Non-Operating Income, excl. Interest Expenses 292.53 K451.93 K174.37 K213.05 K 1.13 M Unusual income/expense 0250 K00 250 K Pretax income 246.49 K-562.65 K-544.76 K480.35 K -380.57 K Equity in earnings ———— — Taxes 2 7602 7601 8253 547 10.89 K Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 243.73 K-565.41 K-546.59 K476.8 K -391.46 K Discontinued operations ———— — Net income 243.73 K-565.41 K-546.59 K476.8 K -391.46 K Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 243.73 K-565.41 K-546.59 K-32.85 K -901.12 K Basic earnings per share (Basic EPS) 0.03-0.06-0.060.05 -0.04 Diluted earnings per share (Diluted EPS) 0.03-0.06-0.06-0 -0.04 Average basic shares outstanding 9.46 M9.46 M9.47 M9.46 M — Diluted shares outstanding 9.54 M9.46 M9.47 M9.46 M — EBITDA -42.21 K-940.16 K-648.4 K349.88 K -1.28 M EBIT -48.68 K-1.02 M-721.77 K264.65 K -1.52 M Cost of revenue 2.44 M2.03 M1.82 M1.27 M 7.57 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 6 47677.06 K73.37 K85.23 K 242.13 K